MedTrace Logo

A Study to Evaluate the Safety and Pharmacokinetics After Oral Concurrent Administration of Fimasartan and Hydrochlorothiazide in Healthy Male Volunteers

NCT00923533 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 34

Last updated 2009-10-08

No results posted yet for this study

Summary

To evaluate drug-drug interaction between fimasartan and hydrochlorothiazide.

Conditions

  • Essential Hypertension

Interventions

DRUG

Fimasartan

Fimasartan (7day) Fimasartan + Hydrochlorothiazide (7day)

DRUG

Hydrochlorothiazide

Hydrochlorothiazide (7day) Fimasartan + Hydrochlorothiazide (7day)

Sponsors & Collaborators

  • Boryung Pharmaceutical Co., Ltd

    lead INDUSTRY

Study Design

Allocation
NON_RANDOMIZED
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
20 Years
Max Age
45 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2009-03-31
Primary Completion
2009-05-31
Completion
2009-08-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00923533 on ClinicalTrials.gov